RISK FACTORS FOR THE DEVELOPMENT AND FEATURES OF THE COURSE OF URATE NEPHROPATHY IN FREQUENTLY ILL CHILDREN

FULL TEXT:

Abstract

Objective: To determine the prevalence, risk factors, and clinical features of urate nephropathy (UN) in frequently ill children (FIC). Materials and Methods: The study was conducted at the multidisciplinary clinic of Tashkent State Medical University, in the Department of Pediatric Nephrology, during the period from 2022 to 2024. At Stage I, a retrospective, in-depth analysis of the medical records of 1,323 children aged 3 to 12 years who received inpatient treatment was carried out. At Stage II, a comprehensive clinical examination was conducted on 120 children with a confirmed diagnosis of UN. Results: Among frequently ill children, diseases of the urinary system, including urate nephropathy, occur significantly more often than in healthy children. In FIC, UN is commonly associated with background diseases such as tonsillitis, bronchitis, gastroduodenitis, and others, and is characterized by marked seasonality. The main risk factors for the development of the disease include maternal comorbidities, which may increase the likelihood of kidney tissue pathologies in the child in the future. In children with UN, clinical manifestations show age-specific features depending on the developmental stage of the child. Conclusion: To prevent complications of urate nephropathy in frequently ill children, early detection of urate metabolism disorders and timely correction are essential.

About the Authors

List of references

Абдуллаева М.М., Рахимов Ш.К. Особенности течения уратной нефропатии у детей с фоновыми инфекциями. Вестник педиатрии. 2023; 12(1):34-39.

Алейников В.Е., Бровкина С.А. Особенности течения уратной нефропатии у детей с хроническими воспалительными заболеваниями. Педиатрический журнал. 2020; 15(4):22-28.

Алиев А.А., Саидов Р.Р. Уратная нефропатия у детей: факторы риска, диагностика, лечение. Журнал Российской детской нефрологии. 2022; 8(2):50-56.

Закирова У.И., Нурматова Н.Ф., Хабибуллаева Б.Р. Диагностическая роль цитокинового профиля при хроническом пиелонефрите у детей: дис- Аpplication of high innovative …, 2023

Кузнецова Т.В., Иванова А.Н. Клиника и диагностика уратной нефропатии у детей. Российский журнал нефрологии. 2021; 13(2):78-85.

Морозова Е.В., Лебедев Д.В. Метаболические нефропатии у детей: современные подходы к терапии. Нефрология и диализ. 2021; 23(3):102-109.

Петряев И.В., Киселева Е.А. Гиперурикемия и уратная нефропатия у детей: современные подходы к диагностике и лечению. Педиатрия. 2019; 98(3):45-52.

Самадов А.А., Нурматова Н.Ф., Маллаев Ш.Ш. Болаларда нефротик синдромда гастродуоденал ўзгаришлар кузатилганда микроэлементлар ҳолати. - Eurasian Journal of Medical and Natural Sciences, 2024. С.114-120

Тураева Н.Ю. Клинические и лабораторные особенности течения дисметаболической нефропатии у детей с нарушением пуринового обмена. Междисциплинарный журнал науки и технологий. 2024; 4(7):276 281.

Cairo MS, Bishop M. Tumor lysis syndrome: new insights. Hematology. 2019;2019(1):349-357.

Chen X, et al. Metabolic syndrome and uric acid in children. J Pediatr Endocrinol Metab. 2020;33(10):1353-1361.

Choi HK, Mount DB. Clinical management of hyperuricemia and gout in children. Pediatr Nephrol. 2019;34(9):1573-1582.

Coiffier B, et al. Management of tumor lysis syndrome. Br J Haematol. 2008;142(1):3-13.

International Society of Nephrology (ISN) Guidelines. Management of hyperuricemia in children. 2023.

Johnson RJ, et al. Uric acid and kidney disease: cause or effect? Curr Opin Nephrol Hypertens. 2013;22(2):169-175.

Karimova B.N., Otajonov I.O., Nurmatova N.F. Causes of development and clinical-laboratory manifestations of urate nephropathy in children.- Central Asian Journal of Medicine, 2023.Р.54-58

Kawasaki H, et al. Long-term outcomes of urate nephropathy in children. Pediatr Nephrol. 2021;36(8):2437-2444.

Kumar A, Gupta N. Pharmacological management of hyperuricemia in pediatric patients. Pediatr Drugs. 2022;24(1):1-10.

Lee JH, et al. Clinical features of urate nephropathy in children. Korean J Pediatr. 2017;60(5):152-158.

Park JS, et al. Diagnostic approach to hyperuricemia. J Clin Nephrol. 2018;13(2):90-99.

Ruzikulov N.Yo. Current Views on Urate Nephropathy in Children. World Bulletin of Public Health. 2024; 32.

Sun Y, et al. Genetic factors in pediatric hyperuricemia. Clin Genet. 2022;101(3):307-316.

Weaver D.J., Warady B.A., Schwartz G.J., et al. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study. Am J Kidney Dis. 2015; 66(6):984 992. DOI: 10.1053/j.ajkd.2015.06.021.

Xu J., Tong L., Mao J. Hyperuricemia and Associated Factors in Children with Chronic Kidney Disease: A Cross Sectional Study. Children. 2022; 9(1):6. DOI: 10.3390/children9010006.

Zakirova U.I., Nurmatova N.F., Khabibullaeva B.R. Diagnostic role of cytokine profile in chronic pyelonephritis in children.- Академические исследования в современной науке, 2025.Р.146-148

Zakirova U.I., Nurmatova N.F., Khabibullaeva B.R. O’tkir pielonefrit bilan kasallangan bolalarda reabilitatsiya tadbirlarini optimallashtirish- 2025

How to Cite

1.
Nurmatova N, Nurmatov U. RISK FACTORS FOR THE DEVELOPMENT AND FEATURES OF THE COURSE OF URATE NEPHROPATHY IN FREQUENTLY ILL CHILDREN. MSU [Internet]. 2025 Dec. 11 [cited 2025 Dec. 13];(6):59-65. Available from: http://fdoctors.uz/index.php/journal/article/view/214
Views: 0